+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lung Cancer Drugs Market Research Reports

From
Lung Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Lung Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Bevacizumab Biosimilars Global Market Report 2024 - Product Thumbnail Image

Bevacizumab Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Capecitabine Global Market Report 2024 - Product Thumbnail Image

Capecitabine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Doxorubicin Global Market Report 2024 - Product Thumbnail Image

Doxorubicin Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Paclitaxel Injection Global Market Report 2024 - Product Thumbnail Image

Paclitaxel Injection Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Small Cell Lung Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Small Cell Lung Cancer Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Doxorubicin - Global Strategic Business Report - Product Thumbnail Image

Doxorubicin - Global Strategic Business Report

  • Report
  • February 2024
  • 288 Pages
  • Global
From
Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • February 2024
  • 184 Pages
  • Global
From
From
From
Loading Indicator

The Lung Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat lung cancer. These drugs are used to treat both non-small cell and small cell lung cancer, the two most common types of lung cancer. The drugs are designed to target the cancer cells and stop them from growing and spreading. Common treatments include chemotherapy, targeted therapy, immunotherapy, and radiation therapy. The Lung Cancer Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies such as Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Roche are all major players in the market. These companies are constantly researching and developing new drugs to treat lung cancer, as well as improving existing treatments. In addition, there are many smaller companies that specialize in the development of new drugs for the treatment of lung cancer. These companies often collaborate with larger pharmaceutical companies to bring their drugs to market. Examples of these companies include ImmunoGen, Inc., Oncolytics Biotech, and ImmunoCellular Therapeutics. Show Less Read more